Fundz

Perth buyer acquires Mayne Pharma's Australian arm

PRIVATENov 09, 2026

Acquiring Company

Perth-based suitor (unnamed)

Acquired Company

Mayne Pharma Group Limited

PerthBiotechnologyPharmaceuticalBiotechnologyHealth CarePharmaceutical

Description

Mayne Pharma announced on Friday that it has found a buyer for its Australian section, including its Salisbury North drugs factory. A Perth-based suitor's $55.5 million bid was accepted by the board, which CEO Aaron Gray described as a defining step in the company's transformation. Mayne shares rose 13.65 per cent in one day and 21.26 per cent for the week.

Who to call at Perth-based suitor (unnamed), and when

When Perth-based suitor (unnamed) changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Perth-based suitor (unnamed) raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Perth-based suitor (unnamed), from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Perth-based suitor (unnamed). With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Perth-based suitor (unnamed)

Location

Perth, Western Australia, Australia

About

The buyer is a Perth-based company that has made a $55.5 million bid for the Australian section of Mayne Pharma, which was accepted by Mayne's board. The text does not name the buyer.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Perth-based suitor (unnamed) makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Perth-based suitor (unnamed)'s next move

Learn about Strategic plan

Frequently asked

Who acquired Mayne Pharma Group Limited?

Mayne Pharma Group Limited was acquired by Perth-based suitor (unnamed), based in Perth. The deal was reported on November 9, 2026. The buyer is a Perth-based company that has made a $55.5 million bid for the Australian section of Mayne Pharma, which was accepted by Mayne's board. The text does not name the buyer. Perth-based suitor (unnamed) is privately held and operates in Biotechnology.

When did Perth-based suitor (unnamed) acquire Mayne Pharma Group Limited?

Perth-based suitor (unnamed)'s acquisition of Mayne Pharma Group Limited was reported on November 9, 2026. Mayne Pharma announced on Friday that it has found a buyer for its Australian section, including its Salisbury North drugs factory. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Mayne Pharma Group Limited do?

Mayne Pharma Group Limited is a pharmaceutical company based in Australia. It has a proven commercial expertise and is known for its strength in women's health and dermatology. It is privately held, operating in Biotechnology.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.